Published in Am Heart J on May 01, 1990
Worcester Heart Attack Community Surveillance Study | NCT00005196
Atrial fibrillation and death after myocardial infarction: a community study. Circulation (2011) 2.63
Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation (2011) 2.63
Treatment of atrial fibrillation in a district general hospital. Br Heart J (1994) 2.40
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32
Factors determining case fatality in myocardial infarction "who dies in a heart attack"? Br Heart J (1995) 1.15
Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One (2011) 1.10
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J (2009) 1.01
Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention. Crit Pathw Cardiol (2011) 0.92
Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts. Br J Pharmacol (2000) 0.89
Dynamic TIMI risk score for STEMI. J Am Heart Assoc (2013) 0.87
Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation. Neth Heart J (2015) 0.84
Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis. Int J Med Sci (2013) 0.79
New-onset versus chronic atrial fibrillation in acute myocardial infarction: differences in short- and long-term follow-up. Clin Res Cardiol (2010) 0.78
Rate control in atrial fibrillation by cooling: effect of temperature on dromotropy in perfused rabbit hearts. Cardiol Res Pract (2011) 0.75
Accurate Detection Of Left Atrial Thrombus Prior To Atrial Fibrillation Ablation In Patients With Therapeutic Anticoagulation: Does Transesophageal Echocardiography Beat Conventional Wisdom? J Atr Fibrillation (2009) 0.75
The prognostic effects of ventricular heart rate among patients with permanent atrial fibrillation with and without coronary artery disease: a multicenter prospective observational study. Medicine (Baltimore) (2015) 0.75
Myocardial infarction, atrial fibrillation and mortality: timing is everything. Neth Heart J (2015) 0.75
Mechanisms underlying the development of atrial arrhythmias in heart failure. Heart Fail Rev (2002) 0.75
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol (2000) 16.47
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Is it time to pull the pulmonary artery catheter? JAMA (1996) 5.69
Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med (2001) 5.05
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost (2009) 4.30
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29
Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA (1986) 4.20
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol (1999) 4.00
Is integrative medicine the medicine of the future? A debate between Arnold S. Relman, MD, and Andrew Weil, MD. Arch Intern Med (1999) 3.33
A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation (1993) 3.31
Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol (1998) 3.16
Health care in America: the good, the bad, and the ugly. Arch Intern Med (2000) 2.92
Paradoxical embolism. Diagnosis during life. Am J Med (1972) 2.85
Natural history of pulmonary embolism. Prog Cardiovasc Dis (1975) 2.83
Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med (1998) 2.80
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1992) 2.76
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest (2001) 2.72
Cholesterol and violent behavior. Arch Intern Med (1994) 2.64
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
Malaria infection of the mosquito Anopheles gambiae activates immune-responsive genes during critical transition stages of the parasite life cycle. EMBO J (1998) 2.62
A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol (1996) 2.60
Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation (1994) 2.53
Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med (1999) 2.46
Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res (2000) 2.34
Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status. N Engl J Med (1980) 2.33
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25
Platelet functions beyond hemostasis. J Thromb Haemost (2009) 2.23
Plasmodium activates the innate immune response of Anopheles gambiae mosquitoes. EMBO J (1997) 2.21
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1998) 2.17
Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack study. Arch Intern Med (2000) 2.16
The accumulation and elimination of crude and clarified poliovirus suxpensions by shellfish. Am J Epidemiol (1969) 2.10
The impact of medical therapy on hemorrhagic complications following coronary artery bypass grafting. Arch Intern Med (1990) 2.06
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02
A novel alpha-type carbonic anhydrase associated with the thylakoid membrane in Chlamydomonas reinhardtii is required for growth at ambient CO2. EMBO J (1998) 2.01
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J (2001) 2.01
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med (1998) 2.01
Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med (1991) 1.99
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol (1998) 1.95
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J (1988) 1.89
Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci U S A (1997) 1.88
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87
Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol (1999) 1.87
Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation. Am J Physiol Gastrointest Liver Physiol (2000) 1.83
Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am J Surg Pathol (1999) 1.82
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med (1994) 1.78
Dinucleotide repeat polymorphism at the MAOA locus. Nucleic Acids Res (1991) 1.77
Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol (1993) 1.77
Sex differences in symptom presentation associated with acute myocardial infarction: a population-based perspective. Am Heart J (1998) 1.75
Sounding Board. CPR training for physicians. N Engl J Med (1980) 1.74
A bold proposal to achieve near-universal health care coverage in the United States. Arch Intern Med (2000) 1.71
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest (1998) 1.67
High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr (1993) 1.64
Loss of skepticism in medical education. Arch Intern Med (1989) 1.62
Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A (1992) 1.60
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med (1991) 1.58
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation (1983) 1.57
Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormality. Am Heart J (1990) 1.55
Duration of, and temporal trends (1994-1997) in, prehospital delay in patients with acute myocardial infarction: the second National Registry of Myocardial Infarction. Arch Intern Med (1999) 1.55
Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol (2001) 1.55
Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart (2003) 1.55
Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes. Heart (2010) 1.53
Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol (1998) 1.51
Temporal trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction. A communitywide perspective. Circulation (1994) 1.51
Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance. J Gen Intern Med (1999) 1.50
Basic life support. J Med Educ (1978) 1.50
Anopheles gambiae Ag-STAT, a new insect member of the STAT family, is activated in response to bacterial infection. EMBO J (1999) 1.49
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1997) 1.49
Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome. Acta Neurol Scand (1999) 1.48
An apple a day or an aspirin a day? Arch Intern Med (1991) 1.48
Late prognosis of acute pulmonary embolism. N Engl J Med (1973) 1.47